# Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia

> **NCT05937841** · EARLY_PHASE1 · RECRUITING · sponsor: **Anna Stanhewicz, PhD** · enrollment: 30 (estimated)

## Conditions studied

- Preeclampsia Postpartum

## Interventions

- **DRUG:** Compound 21

## Key facts

- **NCT ID:** NCT05937841
- **Lead sponsor:** Anna Stanhewicz, PhD
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-28
- **Primary completion:** 2025-08-12
- **Final completion:** 2026-06-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05937841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05937841, "Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05937841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*